These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 28296603)

  • 41. Relationship between prescribing and risk of opiate overdose among drug users in and out of maintenance treatment.
    Man LH; Best D; Gossop M; Stillwell G; Strang J
    Eur Addict Res; 2004; 10(1):35-40. PubMed ID: 14665804
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Does substitution with heroin make sense?].
    Stiefelhagen P
    MMW Fortschr Med; 2016 May; 158(9):12. PubMed ID: 27155680
    [No Abstract]   [Full Text] [Related]  

  • 43. Harm reduction intensity-Its role in HAART adherence amongst drug users in Amsterdam.
    Lambers FA; Stolte IG; van den Berg CH; Coutinho RA; Prins M
    Int J Drug Policy; 2011 May; 22(3):210-8. PubMed ID: 21392958
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Use of intramuscular methadone in managing intravenous drug abuse.
    Bezant EM
    BMJ Case Rep; 2014 Nov; 2014():. PubMed ID: 25414219
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Methadone and buprenorphine maintenance therapies for patients with hepatitis C virus infected after intravenous drug use.
    Verrando R; Robaeys G; Matheï C; Buntinx F
    Acta Gastroenterol Belg; 2005; 68(1):81-5. PubMed ID: 15832591
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Police interference with methadone treatment in Bangkok, Thailand.
    Hayashi K; Ti L; Kaplan K; Suwannawong P; Wood E; Kerr T
    Int J Drug Policy; 2015 Jan; 26(1):112-5. PubMed ID: 25239286
    [No Abstract]   [Full Text] [Related]  

  • 47. [Reduced drug craving and better social function with buprenorphine therapy. Combination therapy as an alternative to methadone therapy in heroin addiction].
    Heilig M; Kakko J
    Lakartidningen; 2003 Aug; 100(32-33):2526-7. PubMed ID: 12959012
    [No Abstract]   [Full Text] [Related]  

  • 48. Science versus politics: the need for supervised injection facilities in Montreal, Canada.
    Jozaghi E
    Int J Drug Policy; 2012 Sep; 23(5):420-1. PubMed ID: 22818890
    [No Abstract]   [Full Text] [Related]  

  • 49. The art and the science of scaling-up needle and syringe programmes.
    Bedell R
    Addiction; 2007 Aug; 102(8):1179-80. PubMed ID: 17624968
    [No Abstract]   [Full Text] [Related]  

  • 50. Buprenorphine-based regimens and methadone for the medical management of opioid dependence: selecting the appropriate drug for treatment.
    Maremmani I; Gerra G
    Am J Addict; 2010; 19(6):557-68. PubMed ID: 20958853
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of reduction in heroin supply on injecting drug use: analysis of data from needle and syringe programmes.
    Day C; Degenhardt L; Gilmour S; Hall W
    BMJ; 2004 Aug; 329(7463):428-9. PubMed ID: 15292056
    [No Abstract]   [Full Text] [Related]  

  • 52. Heroin addiction, methadone, and HIV in China.
    Marienfeld C
    Lancet Psychiatry; 2016 Sep; 3(9):799-800. PubMed ID: 27568260
    [No Abstract]   [Full Text] [Related]  

  • 53. Premenstrual syndrome and self-medication with opioids.
    Qurishi R; Sonneborn C; de Jong-Arts M; de Jong C
    J Addict Med; 2013; 7(1):79-82. PubMed ID: 23314477
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Heroin Use, HIV-Risk, and Criminal Behavior in Baltimore: Findings from Clinical Research.
    Schwartz RP; Kelly SM; Gryczynski J; Mitchell SG; O'Grady KE; Jaffe JH
    J Addict Dis; 2015; 34(2-3):151-61. PubMed ID: 26079104
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Predictors of the severity of depressive symptoms among intravenous heroin users receiving methadone maintenance treatment in Taiwan: an 18-month follow-up study.
    Wang PW; Wu HC; Yen CN; Yeh YC; Chung KS; Chang HC; Yen CF
    Psychol Addict Behav; 2012 Mar; 26(1):145-50. PubMed ID: 21859169
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Opioid-related mortality and filled prescriptions for buprenorphine and methadone.
    Wikner BN; Öhman I; Seldén T; Druid H; Brandt L; Kieler H
    Drug Alcohol Rev; 2014 Sep; 33(5):491-8. PubMed ID: 24735085
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The trajectory of methadone maintenance treatment in Nepal.
    Ambekar A; Rao R; Pun A; Kumar S; Kishore K
    Int J Drug Policy; 2013 Nov; 24(6):e57-60. PubMed ID: 23845916
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Attitudes about prescribing take-home naloxone to injection drug users for the management of heroin overdose: a survey of street-recruited injectors in the San Francisco Bay Area.
    Seal KH; Downing M; Kral AH; Singleton-Banks S; Hammond JP; Lorvick J; Ciccarone D; Edlin BR
    J Urban Health; 2003 Jun; 80(2):291-301. PubMed ID: 12791805
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Brain abscess complicating drug abuse.
    Hayashi T; Buschmann C; Matejic D; Riesselmann B; Tsokos M
    Forensic Sci Med Pathol; 2013 Mar; 9(1):108-11. PubMed ID: 22700342
    [No Abstract]   [Full Text] [Related]  

  • 60. Harm Reduction: Front Line Public Health.
    Stancliff S; Phillips BW; Maghsoudi N; Joseph H
    J Addict Dis; 2015; 34(2-3):206-19. PubMed ID: 26080038
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.